A small study reveals that perfusion CT findings of blood-brain barrier permeability above a specified volume at the time of admission in patients over the age of 65 treated with tPA can predict two “feared complications”-symptomatic hemorrhagic transformation and malignant edema-with 100 percent sensitivity and specificity.
Top news from a featured radiology search on SearchMedica: ct perfusion
Blood-Brain Barrier Permeability Assessed by Perfusion CT Predicts Symptomatic Hemorrhagic Transformation and Malignant Edema in Acute Ischemic StrokeAmerican Journal of Neuroradiology | Jan 1, 2011 (FREE FULL TEXT)
A small study headed by a University of Virginia radiologist reveals that perfusion CT findings of blood-brain barrier permeability above a specified volume at the time of admission in patients over the age of 65 treated with tPA can predict two “feared complications”-symptomatic hemorrhagic transformation and malignant edema-with 100 percent sensitivity and specificity. The team hopes these studies can be used to individualize the use of tPA and perhaps extend the time window for its use.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.